In Abu Dhabi, scientists and doctors have been making groundbreaking advancements in the field of stem cell therapy, harnessing the regenerative power of stem cells to treat various conditions. Established in 2019, the Abu Dhabi Stem Cells Center (ADSCC) has become a leading institution in regenerative medicine, offering transformative treatments to thousands of patients across the UAE.
The center has achieved remarkable progress in stem cell-based therapies, with recent success stories, including the region’s first successful bone marrow transplant for multiple sclerosis and a stem cell trial called ‘UAECell19,’ treating over 20,000 COVID-19 and long COVID patients. The use of hematopoietic stem cell transplantation (HSCT) has also shown promise in treating blood cancer diseases like leukemia and multiple sclerosis.
Stem cells, known as the ‘building blocks of life,’ have immense potential to develop into different cell types and repair damaged tissues, making them suitable for treating a wide range of conditions, including cancer and diabetes.
ADSCC houses cutting-edge research and cell processing laboratories, state-of-the-art units for stem cell collection and apheresis, and a Good Manufacturing Practice (GMP) lab. With an 85-bed hospital in Khalifa City, Abu Dhabi, the center can now provide innovative treatments across various medical specialties.
The center has utilized stem cell therapy in orthopedics, men’s health (addressing erectile dysfunction and Peyronie’s disease), women’s health (treating infertility and gynecological disorders), and lung disorders. Stem cell therapy has also been employed for aesthetic and wellness treatments, targeting hair loss, anti-aging, and IV stem cell therapy for improved overall health and well-being.
With a growing concern about diabetes in the UAE, ADSCC is exploring stem cell therapy as a potential avenue to regenerate insulin-producing cells and improve blood sugar control.
One of ADSCC’s significant achievements during the COVID-19 pandemic was the development of UAE-Cell19, a stem cell therapy that helped thousands of COVID-19 patients fight the virus and recover from post-COVID complications. The treatment’s innovative approach involved nebulization, regenerating lung cells and boosting the body’s immune response.
The center is also researching advanced cellular therapies like CAR-T cells, which target cancer cells, providing a potent tool to combat tumors.
Education is a core focus at ADSCC, where they train the next generation of healthcare professionals, including physicians, nurses, and scientists. Their panel of expert scientists conducts pioneering clinical studies, pushing the boundaries of scientific exploration in the field of Adoptive Cell Therapy.
ADSCC’s mission remains steadfast – to provide world-class stem cell therapy and regenerative medicine, making a lasting impact on patients’ lives and advancing healthcare on a global scale.